Figure 6From: Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines ATO treatment of HepG2 cells results in sustained activation of MAPK and JNK. HepG2 and LX2 cells were treated with vehicle or 5–50 μM ATO as indicated for 24 hrs. Levels of phosphorylated and total MAPK (A) and JNK (B) were assessed by western blot analysis. GAPDH was utilized as a loading control.Back to article page